The Food and Drug Administration on Wednesday approved Medtronic's CoreValve Evolut Pro valve.
Here are three things to know.
1. The heart valve is intended to treat patients with severe aortic stenosis who have a high or extreme risk for open heart surgery, according to a company news release.
2. The CoreValve Evolut Pro contains several design concepts aimed to prevent blood from leaking through the sides of the valve.
3. Clinicians can use Medtronic's EnVeo R Delivery Catheter System to insert the heart valve, which can be used for blood vessels as small as 5.5 millimeters.
More articles on supply chain:
Trump meets with Congressional Black Caucus, promises lower drug costs
Study: Surgeon scorecards reduce supply cost without affecting outcomes
FDA grants tentative approval to Mylan's HIV/AIDS drug: 3 things to know